|
Fuster JL, Molinos-Quintana A, Fuentes C, Fernandez JM, Velasco P, Pascual T, Rives S, Dapena JL, Sisinni L, Lopez-Godino O, Palomo P, Villa-Alcazar M, Bautista F, Gonzalez-Vicent M, Lopez-Duarte M, Garcia-Morin M, Ramos-Elbal E, Ramirez M; Leukemia Working Group of the Spanish Society of Pediatric Hematology, Oncology (SEHOP). Blinatumomab and inotuzumab for B cell precursor acute lymphoblastic leukaemia in children: a retrospective study from the Leukemia Working Group of the Spanish Society of Pediatric Hematology and Oncology (SEHOP). Br J Haematol. 2020 Sep;190(5):764-771. doi: 10.1111/bjh.16647. Epub 2020 Apr 21. PubMed PMID: 32314348.
AÑO: 2020; IF: 6.998
|
32314348
|
Tenorio J, Alarcon P, Arias P, Dapia I, Garcia-Minaur S, Palomares Bralo M, Campistol J, Climent S, Valenzuela I, Ramos S, Monseny AM, Grondona FL, Botet J, Serrano M, Solis M, Santos-Simarro F, Alvarez S, Teixido-Tura G, Fernandez Jaen A, Gordo G, Bardon Rivera MB, Nevado J, Hernandez A, Cigudosa JC, Ruiz-Perez VL, Tizzano EF; SOGRI Consortium; Lapunzina P. Further delineation of neuropsychiatric findings in Tatton-Brown-Rahman syndrome due to disease-causing variants in DNMT3A: seven new patients. Eur J Hum Genet. 2020 Apr;28(4):469-479. doi: 10.1038/s41431-019-0485-3. Epub 2019 Nov 4. PubMed PMID: 31685998; PubMed Central PMCID: PMC7080728.
AÑO: 2020; IF: 4.246
|
|
Munoz Builes M, Vela Cuenca M, Fuster Soler JL, Astigarraga I, Pascual Martinez A, Vagace Valero JM, Tong HY, Valentin Quiroga J, Fernandez Casanova L, Escudero Lopez A, Sisinni L, Blanquer M, Mirones Aguilar I, Gonzalez Martinez B, Borobia AM, Perez-Martinez A. Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia. BMJ Open. 2020 Jan 8;10(1):e029642. doi: 10.1136/bmjopen-2019-029642. PubMed PMID: 31919123; PubMed Central PMCID: PMC6955478.
AÑO: 2020; IF: 2.692
|
|
Vega-Garcia N, Perez-Jaume S, Esperanza-Cebollada E, Vicente-Garces C, Torrebadell M, Jimenez-Velasco A, Ortega M, Llop M, Abad L, Vagace JM, Minguela A, Pratcorona M, Sanchez-Garcia J, Garcia-Calderon CB, Gomez-Casares MT, Martin-Clavero E, Escudero A, Rinon Martinez-Gallo M, Munoz L, Velasco MR, Garcia-Morin M, Catala A, Pascual A, Velasco P, Fernandez JM, Lassaletta A, Fuster JL, Badell I, Molinos-Quintana A, Molines A, Guerra-Garcia P, Perez-Martinez A, Garcia-Abos M, Robles Ortiz R, Pisa S, Adan R, Diaz de Heredia C, Dapena JL, Rives S, Ramirez-Orellana M, Camos M. Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment. Front Pediatr. 2021 Feb 5;8:614521. doi: 10.3389/fped.2020.614521. eCollection 2020. PubMed PMID: 33614543; PubMed Central PMCID: PMC7892614.
AÑO: 2020; IF: 3.418
|
|
Martinez-Sanchez MV, Fuster JL, Campillo JA, Galera AM, Bermudez-Cortes M, Llinares ME, Ramos-Elbal E, Pascual-Gazquez JF, Fita AM, Martinez-Banaclocha H, Galian JA, Gimeno L, Muro M, Minguela A. Expression of NK Cell Receptor Ligands on Leukemic Cells Is Associated with the Outcome of Childhood Acute Leukemia. Cancers (Basel). 2021 May 11;13(10):2294. doi: 10.3390/cancers13102294. PubMed PMID: 34064810; PubMed Central PMCID: PMC8151902.
AÑO: 2021; IF: 6.575
|